What You Should Know:
– Commons Clinic today announced a $26M Series B financing, bringing its total funding to over $60M led by RA Capital, with participation from Floating Point, SteelSky Ventures, Time BioVentures, Courtside Ventures, and Commons Clinic physicians.
– The funding supports the launch of Wholebody by Commons Clinic, a multi-specialty suite connecting all of the organization’s advanced preventative care offerings.
Through early detection, tailored prevention, and accountable intervention, the new Wholebody program furthers Commons Clinic’s mission to reinvent specialty care.
A New Model for Early Detection and Prevention
Wholebody by Commons Clinic places a team of renowned specialists at the center of early detection and prevention. The program consists of five specialty tracks that utilize advanced diagnostic technologies to thoroughly evaluate essential health indicators. These include:
- Cardiometabolic wellness
- Musculoskeletal conditions
- Women’s health
- Weight management
- Hormonal balance
- Gastrointestinal health
- Chronic pain
- Preventive oncology
Each patient program includes up to three specialty consults from Commons Clinic’s national expert network and offers priority placement into its vetted “FastPass” network of primary care partners. This ensures patients experience accelerated, contiguous, and highly accountable care pathways.
Building the “Cleveland Clinic of Tomorrow”
Inspired by world-class institutions like the Mayo Clinic and Cleveland Clinic, Commons Clinic has built its foundation as a musculoskeletal center-of-excellence that combines advanced surgical treatments with thoughtful conservative care. The company’s focus on a vertically integrated model for delivering world-class interventional specialty care has attracted strong investor support. Board-certified cardiologist Dr. Jenica Ortega will lead the new Wholebody program, with a specific focus on building its cardiac, metabolic, bariatric, and women’s health service lines. Additionally, Brad Hively, the former CEO of The Oncology Institute, has recently joined Commons’ board to advise on its specialty value-based care strategy and expansion.
“What sets Commons Clinic apart is its focus on delivering world-class interventional specialty care seamlessly through a vertically integrated model,” said John Loser, Managing Director at Floating Point. “Through its deep expertise in complex ambulatory surgical care and extraordinary concentration of top-tier specialty talent, Commons Clinic is reimagining the future of specialty care and building the Cleveland Clinic of tomorrow.”
